ACTRN12617000747325尚未招募2 期
A multi-centre double blind randomised controlled trial of continuous subcutaneous lidocaine (lignocaine) for the management of neuropathic cancer pain - a feasibility study.
niversity of Technology Sydney0 个研究点目标入组 36 人开始时间: 2017年5月22日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 36
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 —（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A double-blind multi-centre randomised controlled trial to investigate the effectiveness of methylprednisolone injections in the treatment of Morton's neuromaMorton's neuromaNervous System DiseasesMononeuropathies of lower limbISRCTN13668166Queen Margaret University (UK)150
已完成
4 期
An intervention study to determine if a longer duration of antibiotics (compared to shorter duration) improves the short and long term clinical outcomes of children hospitalised for pneumoniaPneumonia in childrenRespiratory - Other respiratory disorders / diseasesInfection - Studies of infection and infectious agentsPublic Health - Other public healthACTRN12616000046404Menzies School of Health Research324
招募中
3 期
Preventing recurrent acute lower respiratory infections in young Indigenous children using long-term, once-weekly azithromycin: a multicentre randomised controlled trialAcute lower respiratory infection in childrenRespiratory - Other respiratory disorders / diseasesInfection - Other infectious diseasesACTRN12619000456156Menzies School of Health Research160
已完成
4 期
The Rabeprazole and Esomeprazole Reflux Assessment TrialGastro-oesophageal reflux diseasePhysical Medicine / Rehabilitation - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12607000006448Janssen-Cilag Pty Ltd1,908
已完成
不适用
A controlled randomised double-blind multicentre study comparing two therapy strategies in disease modifying anti-rheumatic drug-naive early rheumatoid arthritis patients over 48 weeks: induction therapy with adalimumab and methotrexate over 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate monotherapyISRCTN36745608Charité - University Medicine Berlin (Germany)180